课题基金 / 基金详情

Analysis by cDNA array of altered gene expression in mouse cultured podocytes in response to plasma from recurrent-focal segmental glomerulosclerosis patients

Analysis by cDNA array of altered gene expression in mouse cultured podocytes in response to plasma from recurrent-focal segmental glomerulosclerosis patients
通过 cDNA 阵列分析小鼠培养足细胞响应复发性局灶节段性肾小球硬化患者血浆而改变的基因表达
批准号:
14570775
负责人:
HATTORI Motoshi
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

HATTORI Motoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Circulating factors, a putative podocyte toxin postulated to be responsible for rapid recurrence of nephrotic syndrome (NS) in patients with primary focal segmental glomerulosclerosis (FSGS), are yet to be fully identified despite the availability of encouraging approaches (Savin et al., JASN, 2000). In this study, we attempted to identify a "signature" of FSGS factors. Using the cDNA array technique as the first step, we investigated the modification of gene expression in a conditionally immortalized mouse podocyte cell line after in vitro stimulation with plasma from patients with recurrent FSGS after transplantation (n=3), compared to plasma from patients with non-recurrent FSGS after transplantation (n=2), non-FSGS NS (n=2 ; MCNS and HSPN) and healthy controls. The cells were incubated with 5% v/v of plasma for 48 hours, after which total RNA was extracted. After DNAase treatment, randomly labeled cDNA probes were prepared by reverse transcription using specific primers of each arrayed gene. Denatured probes were hybridized to the cDNA array and analyzed using a bio-imaging analyzer, and up/down-regulation was considered to have occurred if there was more or less than doubling or half of the expression level. Selected findings were further confirmed and quantified by RT-PCR and a real-time PCR assay. When the gene expression profiles from cells incubated with different plasma samples were compared, it was noteworthy that integrin-linked kinase (ILK) was up-regulated only in the relapsing FSGS patients. In conclusion, our preliminary results indicate that ILK may play a role in the pathogenesis in the development of recurrent FSGS after transplantation.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Hattori M et al.: "A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children"American Journal of Kidney Diseases. 42(6). 1121-1130 (2003)
Hattori M 等人:“低密度脂蛋白血浆分离术和泼尼松联合疗法治疗儿童类固醇抵抗性原发性局灶节段性肾小球硬化症”美国肾脏病杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hattori M et al.: "Induction of integrin-Linked kinase(ILK) in mouse cultured podocytes after stimulation with plasma from reccurrent focal segmental glomeruloshlerais"J Am Soc Nephrol. 14. 375A (2003)
Hattori M 等人:“用复发性局灶节段性肾小球肾小球血浆刺激后,小鼠培养的足细胞中整合素连接激酶 (ILK) 的诱导”J Am Soc Nephrol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hattori M et al.: "Analysis by cDNA array of altered gene expression in mouse cultured podocytes in response to plasma from focal segmental glomerulosclerosis patients"Journal of the American Society of Nephrology. 13. 123A (2002)
Hattori M 等人:“通过 cDNA 阵列分析小鼠培养的足细胞响应局灶节段性肾小球硬化症患者血浆而改变的基因表达”美国肾病学会杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hattori M et al.: "Analysis by cDNA array of altered gene expression in mouse cultured podocytes in response to plasma from focal segmental glomerulosclerosis patients."J Am Soc Nephrol. 13. 123A (2002)
Hattori M 等人:“通过 cDNA 阵列分析小鼠培养的足细胞响应局灶节段性肾小球硬化患者血浆而改变的基因表达。”J Am Soc Nephrol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    Phenotypically changed mesangial cells glomerulosclerosis associated with hyperlipidemia in primary FSGS.
    • 批准号:
      08671306
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.02万
    • 财政年份:
      1996
    • 负责人:
      HATTORI Motoshi
    • 依托单位:
    国内基金
    海外基金
    足细胞中补体系统活化以及在足细胞损伤中作用机制研究
    • 批准号:
      81170657
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2011
    • 负责人:
      丁洁
    • 依托单位:
    蛋白尿时肾小球足细胞"重塑"的作用分子及分子机制研究
    • 批准号:
      30830105
    • 项目类别:
      重点项目
    • 资助金额:
      185.0万元
    • 批准年份:
      2008
    • 负责人:
      丁洁
    • 依托单位:
    从离子通道蛋白TRPC6角度探讨突变podocin致足细胞损伤的分子机制
    • 批准号:
      30801250
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2008
    • 负责人:
      范青锋
    • 依托单位: